Brendan Prideaux

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 5

Top Topics

Human Immunodeficiency Virus

Mass Spectrometry

Mycobacterium Tuberculosis

Top Venues

Cancer reports (Hoboken, N.J.)

Analytical chemistry

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Matthias Holzlechner, Eliseo A Eugenin, Brendan Prideaux
Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer. Cancer reports (Hoboken, N.J.) 2 (6) (2021)
Dalin Rifat, Brendan Prideaux, Radojka M Savic, Michael E Urbanowski, Teresa L Parsons, Brian M Luna, Mark A Marzinke, Alvaro A Ordonez, Vincent P DeMarco, Sanjay K Jain, Veronique Anne Dartois, William R Bishai, Kelly E Dooley
Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data. Science translational medicine 10 (435) (2019)
Landry Blanc, Jansy Passiflora Sarathy, Nadine Alvarez Cabrera, Paul O'Brien, Isabela Dias-Freedman, Marizel Mina, James C Sacchettini, Radojka M Savic, Martin Gengenbacher, Brendan K Podell, Brendan Prideaux, Thomas Ioerger, Thomas Dick, Veronique Anne Dartois
Impact of immunopathology on the antituberculous activity of pyrazinamide. The Journal of experimental medicine 215 (8) (2018)
Landry Blanc, Anne Lenaerts, Véronique Dartois, Brendan Prideaux
Visualization of Mycobacterial Biomarkers and Tuberculosis Drugs in Infected Tissue by MALDI-MS Imaging. Analytical chemistry 90 (10) (2018)
Valentina Guerrini, Brendan Prideaux, Landry Blanc, Natalie Bruiners, Riccardo Arrigucci, Sukhwinder Singh, Hsin Pin Ho-Liang, Hugh Salamon, Pei-Yu Chen, Karim Lakehal, Selvakumar Subbian, Paul O'Brien, Laura E Via, Clifton E Barry, Véronique Dartois, Maria Laura Gennaro
Storage lipid studies in tuberculosis reveal that foam cell biogenesis is disease-specific. PLoS pathogens 14 (8) (2018)